MIR1256: A Drug Target / Disease Biomarker (G100302155)
MIR1256: A Drug Target / Disease Biomarker
MIR1256 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes a family of transmembrane proteins that are involved in various signaling pathways. One of the main functions of MIR1256 is to regulate the levels of glucose in the body.
MIR1256 is expressed in the brain, where it is involved in the regulation of dopamine release and uptake. It has been shown to play a role in the development and progression of various neurological disorders, including Parkinson's disease and Alzheimer's disease.
In addition to its role in neurological development, MIR1256 is also involved in the regulation of glucose metabolism. It has been shown to interact with various enzymes involved in glucose metabolism, including GLUT1 and GLUT4. GLUT1 is a glucose transporter that is involved in the uptake of glucose from the bloodstream into the brain, while GLUT4 is a protein that is involved in the regulation of glucose sensitivity.
MIR1256 has also been shown to play a role in the regulation of inflammation. It has been shown to interact with various immune cells, including T cells and macrophages. These interactions may help to contribute to the immune response that occurs in response to infection or inflammation.
MIR1256 is also involved in the regulation of cell survival. It has been shown to play a role in the regulation of cell cycle progression, as well as the apoptosis (programmed cell death) process. This may help to contribute to the regulation of cell survival and the development of cancer.
In conclusion, MIR1256 is a protein that is involved in various signaling pathways in the body. Its functions in neurological development, glucose metabolism, inflammation, and cell survival make it an attractive target for research into the development of new treatments for a variety of disorders. Further research is needed to fully understand the role of MIR1256 in these processes and to develop effective therapies.
Protein Name: MicroRNA 1256
The "MIR1256 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1256 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141
